rs35303786

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198578.4(LRRK2):​c.4937T>C​(p.Met1646Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0142 in 1,611,888 control chromosomes in the GnomAD database, including 220 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 14 hom., cov: 33)
Exomes 𝑓: 0.015 ( 206 hom. )

Consequence

LRRK2
NM_198578.4 missense

Scores

2
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 5.68
Variant links:
Genes affected
LRRK2 (HGNC:18618): (leucine rich repeat kinase 2) This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003975332).
BP6
Variant 12-40320097-T-C is Benign according to our data. Variant chr12-40320097-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 39200.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-40320097-T-C is described in Lovd as [Likely_benign]. Variant chr12-40320097-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0103 (1564/152200) while in subpopulation NFE AF= 0.0158 (1073/67958). AF 95% confidence interval is 0.015. There are 14 homozygotes in gnomad4. There are 728 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1564 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRK2NM_198578.4 linkc.4937T>C p.Met1646Thr missense_variant Exon 34 of 51 ENST00000298910.12 NP_940980.4 Q5S007Q17RV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRK2ENST00000298910.12 linkc.4937T>C p.Met1646Thr missense_variant Exon 34 of 51 1 NM_198578.4 ENSP00000298910.7 Q5S007

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1564
AN:
152082
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.0493
Gnomad AMR
AF:
0.0104
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00480
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0158
Gnomad OTH
AF:
0.0173
GnomAD3 exomes
AF:
0.00937
AC:
2340
AN:
249600
Hom.:
17
AF XY:
0.00946
AC XY:
1278
AN XY:
135160
show subpopulations
Gnomad AFR exome
AF:
0.00227
Gnomad AMR exome
AF:
0.00408
Gnomad ASJ exome
AF:
0.0208
Gnomad EAS exome
AF:
0.0000545
Gnomad SAS exome
AF:
0.00280
Gnomad FIN exome
AF:
0.00389
Gnomad NFE exome
AF:
0.0153
Gnomad OTH exome
AF:
0.00906
GnomAD4 exome
AF:
0.0146
AC:
21383
AN:
1459688
Hom.:
206
Cov.:
34
AF XY:
0.0143
AC XY:
10377
AN XY:
726152
show subpopulations
Gnomad4 AFR exome
AF:
0.00195
Gnomad4 AMR exome
AF:
0.00477
Gnomad4 ASJ exome
AF:
0.0216
Gnomad4 EAS exome
AF:
0.0000505
Gnomad4 SAS exome
AF:
0.00362
Gnomad4 FIN exome
AF:
0.00474
Gnomad4 NFE exome
AF:
0.0172
Gnomad4 OTH exome
AF:
0.0143
GnomAD4 genome
AF:
0.0103
AC:
1564
AN:
152200
Hom.:
14
Cov.:
33
AF XY:
0.00978
AC XY:
728
AN XY:
74422
show subpopulations
Gnomad4 AFR
AF:
0.00255
Gnomad4 AMR
AF:
0.0104
Gnomad4 ASJ
AF:
0.0222
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00352
Gnomad4 FIN
AF:
0.00480
Gnomad4 NFE
AF:
0.0158
Gnomad4 OTH
AF:
0.0171
Alfa
AF:
0.0142
Hom.:
26
Bravo
AF:
0.0110
TwinsUK
AF:
0.0186
AC:
69
ALSPAC
AF:
0.0176
AC:
68
ESP6500AA
AF:
0.00341
AC:
15
ESP6500EA
AF:
0.0154
AC:
132
ExAC
AF:
0.00909
AC:
1103
Asia WGS
AF:
0.00145
AC:
6
AN:
3472
EpiCase
AF:
0.0158
EpiControl
AF:
0.0171

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Sep 21, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 25821816, 21885347, 24470158, 23913756) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Aug 07, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Autosomal dominant Parkinson disease 8 Benign:2Other:1
-
GeneReviews
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

Mar 08, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

LRRK2-related disorder Benign:1
Nov 27, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
21
DANN
Benign
0.93
DEOGEN2
Benign
0.25
T
Eigen
Benign
0.013
Eigen_PC
Benign
0.20
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.0040
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Uncertain
2.3
M
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.18
Sift
Benign
0.16
T
Sift4G
Pathogenic
0.0010
D
Polyphen
0.0010
B
Vest4
0.39
MVP
0.86
MPC
0.10
ClinPred
0.023
T
GERP RS
5.7
Varity_R
0.57
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35303786; hg19: chr12-40713899; COSMIC: COSV100111542; COSMIC: COSV100111542; API